CELLECT BIOTECHNOLOGY LTD
CUSIP 15116C102
Cellect Biotechnology Ltd has 7 institutional holders in Filings Flow’s 13F database, together reporting 328.5K shares worth $157,000 as of Q3 2019. The largest reported holders are Sabby Management, LLC, Wedbush Securities Inc, and Susquehanna International Group, LLP.
Institutional Holders
7
Q3 2019
Reported Value
$157,000
Ticker
unmapped
private placement or foreign
Quarters Tracked
4
Ownership Trend
Institutional holders
Total reported value
Holders
Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| TWO SIGMA SECURITIES, LLC$861M AUM | 0.00% | $9,000 | 19.4K | Q3 2019OLDER |
| Raymond James Financial Services Advisors, Inc.$75.1B AUM | 0.00% | $6,000 | 11.3K | Q2 2019OLDER |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP$893.3B AUM | 0.00% | $44,000 | 95.0K | Q3 2019OLDER |
| CITADEL ADVISORS LLC$618.5B AUM | 0.00% | $12,000 | 25.1K | Q3 2019OLDER |
| DEUTSCHE BANK AG\$302.7B AUM | 0.00% | $8,000 | 17.9K | Q3 2019OLDER |
| UBS Group AG$666.3B AUM | 0.00% | $3,000 | 5.6K | Q3 2019OLDER |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.